2006
DOI: 10.1016/j.cardiores.2006.03.006
|View full text |Cite
|
Sign up to set email alerts
|

Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts

Abstract: Deficiency of ADA does not alter sensitivities of cardiovascular A1 or A2ARs (despite markedly elevated [adenosine]), but significantly improves ischaemic tolerance. Conversely, A1AR deficiency impairs ischaemic tolerance. Effects of ADA deficiency on diastolic pressure appear solely A1AR-dependent while other ARs or processes additionally contribute to improved contractile recovery and reduced cell death.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
24
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(27 citation statements)
references
References 53 publications
3
24
0
Order By: Relevance
“…Adenosine deaminase (ADA)-deficient mice (Blackburn et al, 1998) were maintained on ADA enzyme therapy as described previously (Blackburn et al, 2000) until the age of 6 weeks. An increase in adenosine levels in the hearts was induced by withdrawing mice from enzyme therapy for 15 days before experiments (Willems et al, 2006). The H-2K b -tsA58 transgenic mice on a C57BL/6 genetic background (Immortomouse) were purchased from Charles River Laboratories International, Inc. (Wilmington, MA).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Adenosine deaminase (ADA)-deficient mice (Blackburn et al, 1998) were maintained on ADA enzyme therapy as described previously (Blackburn et al, 2000) until the age of 6 weeks. An increase in adenosine levels in the hearts was induced by withdrawing mice from enzyme therapy for 15 days before experiments (Willems et al, 2006). The H-2K b -tsA58 transgenic mice on a C57BL/6 genetic background (Immortomouse) were purchased from Charles River Laboratories International, Inc. (Wilmington, MA).…”
Section: Methodsmentioning
confidence: 99%
“…A considerable increase in the stromal to endothelial cell ratio ؊ Stromal and Sca-1 ؉ CD31 ؉ Endothelial Cells Induced by Adenosine In Vivo. Withdrawal from ADA enzyme replacement therapy for 2 weeks has been reported to increase adenosine levels in hearts of ADA-deficient mice (Willems et al, 2006). We used this model to evaluate in vivo the effects of adenosine on VEGF production by cardiac stromal and endothelial cells.…”
Section: Cd31mentioning
confidence: 99%
See 1 more Smart Citation
“…A 1 AR signaling has also been shown to protect cells from damage. Deletion of adenosine deaminase leads to elevated adenosine levels and protects the heart from ischemic/ reperfusion injury (18,19). Overexpression of A 1 AR also helps to protect the heart from ischemic/reperfusion injury and conversely the loss of A 1 AR impairs ischemic tolerance (18,19).…”
mentioning
confidence: 99%
“…Deletion of adenosine deaminase leads to elevated adenosine levels and protects the heart from ischemic/ reperfusion injury (18,19). Overexpression of A 1 AR also helps to protect the heart from ischemic/reperfusion injury and conversely the loss of A 1 AR impairs ischemic tolerance (18,19). In addition, adenosine signaling through the A 2a receptor has shown to be protective under hypoxic conditions in the lung by inhibiting the immune response (8).…”
mentioning
confidence: 99%